The rapid spread of the SARS-CoV-2 Omicron variant suggests that the virus might become
globally dominant. Further, the high number of mutations in the viral spike protein raised …

Currently approved viral vector-based and mRNA-based vaccine approaches against
coronavirus disease 2019 (COVID-19) consider only homologous prime-boost vaccination. After …

1 Arora P, Zhang L, Krüger N, et al. SARS-CoV-2 omicron sublineages show comparable
cell entry but differential neutralization by therapeutic antibodies. Cell Host Microbe 2022; …

The SARS-CoV-2 omicron (B. 1.1. 529) variant has rapidly become globally dominant,
displacing the previously dominant delta (B1. 617.2) variant. The viral spike (S) protein is the key …

Neutralizing antibodies targeting the receptor-binding domain (RBD) of the SARS-CoV-2 spike
(S) block severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into cells …

Co-infection with multiple SARS-CoV-2 lineages can result in recombination of the viral
genomes and the emergence of novel, recombinant SARS-CoV-2 lineages. 1–4 In January, 2022…

1 Bardsley M, Morbey RA, Hughes HE, et al. Epidemiology of respiratory syncytial virus in
children younger than 5 years in England during the COVID-19 pandemic, measured by …

Since late 2022, the share of infections caused by the SARS-CoV-2 lineage XBB. 1.5 has
gradually increased in the United States, resulting in XBB. 1.5 becoming the dominating SARS-…

There have been concerns about high rates of thus far undiagnosed SARS-CoV-2 infections
in the health-care system. The COVID-19 Contact (CoCo) Study follows 217 frontline health-…

Background Patients with chronic renal insufficiency on maintenance haemodialysis face
an increased risk of COVID-19 induced mortality and impaired vaccine responses. To date, …